| Thu, Dec 17, 2009 | | • | YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
PR Newswire (Thu, Dec 17)
| | Thu, Dec 10, 2009 | | • | Ym Biosciences Offer for Cytopia Approved to Proceed to Shareholder Vote by Australian Court
PR Newswire (Thu, Dec 10)
| | • | Ym Biosciences and the National Research Council of Canada Biotechnology Research Institute (Nrc-Bri) Produce New Breast Cancer Drug Candidates
PR Newswire (Thu, Dec 10)
| | Mon, Nov 23, 2009 | | • | Ym Biosciences Reports First Patient in Phase I/II Trial of Jak1/Jak2 Inhibitor, Cyt387 Enrolled by Cytopia
PR Newswire (Mon, Nov 23)
| | Wed, Nov 18, 2009 | | • | Ym Biosciences Announces Nimotuzumab Results in Advanced Triple-Negative Breast Cancer Model Presented at Aacr-Nci-Eortc Meeting
PR Newswire (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | Ym Biosciences Reports Cyt997 Oral Vascular Disrupting Agent Results Presented at Aacr-Nci-Eortc Meeting
PR Newswire (Tue, Nov 17)
| | Wed, Nov 11, 2009 | | • | Ym Biosciences Reports Fiscal First Quarter 2010 Operational and Financial Results
PR Newswire (Wed, Nov 11)
| | Thu, Nov 5, 2009 | | • | Coverage initiated on YM BioSciences by Merriman
Briefing.com (Thu, Nov 5)
| | Mon, Nov 2, 2009 | | • | Ym Biosciences Reports Positive Nimotuzumab Four-Year Survival Data Presented at Astro 2009
PR Newswire (Mon, Nov 2)
| | Thu, Oct 29, 2009 | | • | Ym Biosciences Reports Additional Results From Nimotuzumab Phase III Study in Children With Glioma Presented by Oncoscience Ag
PR Newswire (Thu, Oct 29)
| | Mon, Oct 5, 2009 | | • | Ym Biosciences Announces Offer for Cytopia Ltd., an Australian Cancer-Focused Development Company
PR Newswire (Mon, Oct 5)
| | Thu, Oct 1, 2009 | | • | YM BIOSCIENCES INC Financials
EDGAR Online Financials (Thu, Oct 1)
| | Fri, Aug 14, 2009 | | • | Dendreon, Vion and Allos: Biotech Mailbag
at TheStreet.com (Fri, Aug 14)
|
Add YMI News to My Yahoo!:
 
| |
|
0.03% Nasdaq 
0.0199 (1.45%) 
Headlines
